Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/14/2022 | 140% | Goldman Sachs | $2.8 → $2.4 | Maintains | Neutral |
08/12/2022 | 400% | DA Davidson | $11 → $5 | Maintains | Buy |
06/03/2022 | 400% | Northland Capital Markets | → $5 | Initiates Coverage On | → Outperform |
12/17/2021 | 150% | B of A Securities | $3 → $2.5 | Maintains | Underperform |
12/08/2021 | 200% | B of A Securities | → $3 | Initiates Coverage On | → Underperform |
12/03/2021 | 325% | Goldman Sachs | → $4.25 | Initiates Coverage On | → Neutral |
11/12/2021 | 1200% | DA Davidson | $15 → $13 | Maintains | Buy |
10/11/2021 | 900% | Wedbush | → $10 | Initiates Coverage On | → Outperform |
08/26/2021 | 1400% | DA Davidson | $19 → $15 | Maintains | Buy |
What is the target price for Xos (XOS)?
The latest price target for Xos (NASDAQ: XOS) was reported by Goldman Sachs on November 14, 2022. The analyst firm set a price target for $2.40 expecting XOS to rise to within 12 months (a possible 140.00% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Xos (XOS)?
The latest analyst rating for Xos (NASDAQ: XOS) was provided by Goldman Sachs, and Xos maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Xos (XOS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Xos, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Xos was filed on November 14, 2022 so you should expect the next rating to be made available sometime around November 14, 2023.
Is the Analyst Rating Xos (XOS) correct?
While ratings are subjective and will change, the latest Xos (XOS) rating was a maintained with a price target of $2.80 to $2.40. The current price Xos (XOS) is trading at is $1.00, which is out of the analyst's predicted range.